News from astrazeneca A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

10 Apr, 2016, 13:30 BST Pooled Analysis From Seven Clinical Studies Demonstrates Consistent Efficacy for Ceftazidime-avibactam in the Treatment of Multi-drug Resistant Gram-negative Bacteria

Encouraging new data relevant to escalating Gram-negative infection crisis presented at 26th European Congress of Clinical Microbiology and...


14 Oct, 2015, 11:05 BST How Young is Your Heart?

The news is full of stories about how important it is to keep your heart healthy, but have you ever wondered what your heart age is? To mark National ...


31 May, 2015, 14:00 BST AstraZeneca Presents Positive Data on AZD9291 in First-Line EGFR Mutated Lung Cancer at ASCO 2015

AstraZeneca today announced preliminary efficacy and safety data for AZD9291 in the first-line treatment of epidermal growth factor receptor mutation ...


27 Apr, 2015, 08:00 BST Positive Phase III Results for Two Antibiotics, Zinforo™▼ and Investigational Ceftazidime-Avibactam, Presented at Leading Infectious Diseases Conference

Encouraging new data of relevance to Global public health crisis, presented at 25th European Congress of Clinical Microbiology and Infectious...


17 Apr, 2015, 15:30 BST "Real World" Data Support Use of Blood Test for EGFR Mutation in Advanced NSCLC

ASSESS shows plasma circulating tumour DNA (ctDNA) testing for EGFR mutation is a viable alternative to tumour biopsy IGNITE supports value of EGFR...


19 Jun, 2014, 19:58 BST Data Published In The New England Journal Of Medicine Demonstrate Naloxegol Improved Opioid-Induced Constipation In Chronic Pain Patients

AstraZeneca today announced that the New England Journal of Medicine (NEJM) has published results of two pivotal Phase III studies – KODIAC-4 and...


31 May, 2014, 14:05 BST Investigational Drug AZD9291 Shows Clinical Responses in Patients With Advanced NSCLC Who Have Previously Failed on Established EGFR TKIs

Data from the ongoing Phase I AURA study in patients with epidermal growth factor receptor mutation positive (EGFRm+), advanced non-small cell lung...


12 May, 2014, 07:00 BST New Data Shows ZINFORO™ is More Effective Compared to Ceftriaxone in Adult Patients With Community Acquired Pneumonia in the Asian Region

Phase III Data presented at 24th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) AstraZeneca has announced results from a ...


01 Aug, 2013, 14:27 BST New Antibiotic Treatment for Patients With Serious Skin Infections Becomes Available in Wales

For UK medical media and Welsh regional reporters only The All Wales Medicines Strategy Group (AWMSG) has recommended Zinforo®▼ (ceftaroline...


29 Oct, 2012, 12:00 GMT AstraZeneca Begins a New Global Study of FASLODEX® (Fulvestrant) 500 mg Injection in Patients With Hormone Receptor-Positive Advanced Breast Cancer

FALCON (Fulvestrant and AnastrozoLe COmpared in hormonal therapy Naïve advanced breast cancer) trial to compare fulvestrant to anastrozole...


28 May, 2012, 06:00 BST Data Presented at the European Atherosclerosis Society Congress Reinforces the Differentiating Benefits of CRESTOR[TM] in Comparison to Atorvastatin and Simvastatin

THIS RELEASE IS INTENDED EXCLUSIVELY FOR EUROPEAN MEDIA Data presented today from the VOYAGER study demonstrate the benefits of aggressive statin...


31 Mar, 2012, 19:54 BST New European Real World Data Show High Requirement for Treatment Modification and Use of Hospital Resources Associated with First-Line Antibiotic Use for Serious Skin Infections and Pneumonia

Findings of the new REACH study (a REtrospective study to Assess the Clinical Management of Patients With Moderate-to-severe cSSTI or CAP Infections...


26 Mar, 2012, 18:30 BST Crestor Delivers Latest LDL-C Targets in High-Risk Patients at Lower Doses than Other Statins

Results presented from new VOYAGER sub-analysis This release is INTENDED EXCLUSIVELY FOR EUROPEAN media AstraZeneca today announced the results of a...


02 Feb, 2012, 10:40 GMT AstraZeneca Fourth Quarter and Full-Year 2011 Results - Interviews

AstraZeneca, the Anglo-Swedish pharmaceutical company, said that government price intervention had reduced its revenues by about $1bn as it announced ...


18 Nov, 2011, 11:30 GMT CAPRELSA™ (vandetanib) Receives Positive CHMP Opinion in the European Union for Treating Advanced Medullary Thyroid Cancer

AstraZeneca today announced that the Marketing Authorisation Application for CAPRELSA (vandetanib) received a positive opinion from the Committee for ...


30 Aug, 2011, 07:30 BST New ESC Guidelines Recommend BRILIQUE (ticagrelor) in all Moderate-To-High Risk Patients With Non-ST Elevation Acute Coronary Syndromes

- This release is not intended for US media Ticagrelor Recommended for Medically & Invasively Managed NSTE-ACS Patients Regardless of Prior Treatment ...


29 Aug, 2011, 07:30 BST CRESTOR Delivers Superior Efficacy in Achievement of Low LDL-C Targets in New VOYAGER Analysis

? - This release is not intended for US and Canadian media AstraZeneca today announced the results of a sub-analysis from the VOYAGER individual...


29 Aug, 2011, 07:30 BST BRILINTA Mortality Benefit in Blinded Review of Post-CABG PLATO Patients Driven by Fewer Cardiac, Bleeding and Infection Complications as Compared to Clopidogrel

This Release is Not Intended for US Media Additional Analyses from PLATO, Presented at ESC Congress, Examined Impact of BRILINTA vs. Clopidogrel on...


27 Jan, 2011, 07:50 GMT AstraZeneca - Q4 and Full-Year Results Interview

AstraZeneca said its full-year results had outperformed guidance, with growth in emerging markets compensating for patent expiries and pricing...